These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 25478903)

  • 1. Paraprotein interference in immunoassays.
    LeGatt DF; Higgins TN
    Ther Drug Monit; 2015 Jun; 37(3):417. PubMed ID: 25478903
    [No Abstract]   [Full Text] [Related]  

  • 2. Possible false-negative results on therapeutic drug monitoring of phenytoin using a particle enhanced turbidimetric inhibition immunoassay in a patient with a high level of IgM.
    Hirata K; Saruwatari J; Enoki Y; Iwata K; Urata Y; Aizawa K; Ueda K; Shirouzono T; Imamura M; Moriuchi H; Ishima Y; Kadowaki D; Watanabe H; Hirata S; Maruyama T; Fukunaga E
    Ther Drug Monit; 2014 Oct; 36(5):553-5. PubMed ID: 24632808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PETINIA total phenytoin assay on the vista 1500 analyzer is not suitable for monitoring free phenytoin concentration if ultrafiltration is performed at room temperature.
    Dasgupta A; Everett JM; Davis B
    Ther Drug Monit; 2013 Jun; 35(3):384-7. PubMed ID: 23666578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison of i-PiT, TDX and EMIT measurement of serum phenytoin and digoxin levels].
    Koizumi F; Kumai M; Ishimori A
    Rinsho Byori; 1985 Jul; 33(7):761-70. PubMed ID: 3906186
    [No Abstract]   [Full Text] [Related]  

  • 5. Cross-reactivity of fosphenytoin in four phenytoin immunoassays.
    Datta P; Dasgupta A
    Clin Chem; 1998 Mar; 44(3):696-7. PubMed ID: 9510897
    [No Abstract]   [Full Text] [Related]  

  • 6. Analytical validation of a quantitative method for therapeutic drug monitoring on the Alinity
    Dubois N; Sqalli G; Gilson M; Charlier C
    Ann Biol Clin (Paris); 2020 Apr; 78(2):147-155. PubMed ID: 32319943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Undetectable phenytoin serum levels by an automated particle-enhanced turbidimetric inhibition immunoassay in a patient with monoclonal IgM lambda.
    Brauchli YB; Scholer A; Schwietert M; Krähenbühl S
    Clin Chim Acta; 2008 Mar; 389(1-2):174-6. PubMed ID: 18082631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of immune complexes on immunoglobulin assays by turbidimetric immuno assay].
    Miura T; Yabuki S; Terasaki S; Hamazaki T; Ouchi E
    Rinsho Byori; 1985 Aug; 33(8):935-9. PubMed ID: 4079069
    [No Abstract]   [Full Text] [Related]  

  • 9. False increase in serum C-reactive protein caused by monoclonal IgM-lambda: a case report.
    Yu A; Pira U
    Clin Chem Lab Med; 2001 Oct; 39(10):983-7. PubMed ID: 11758616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum free light chain immunoassays: a guide to antigen excess detection.
    Jenner E; Levoguer A; Evans J; Harding S
    Clin Chim Acta; 2012 May; 413(9-10):949; author reply 952. PubMed ID: 22285773
    [No Abstract]   [Full Text] [Related]  

  • 11. Hydroxyzine and metabolites as a source of interference in carbamazepine particle-enhanced turbidimetric inhibition immunoassay (PETINIA).
    Parant F; Moulsma M; Gagnieu MC; Lardet G
    Ther Drug Monit; 2005 Aug; 27(4):457-62. PubMed ID: 16044102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interference with nephelometric assay of C-reactive protein by monoclonal immunoglobulin.
    Lammers M
    Clin Chem; 1998 Jul; 44(7):1584-5. PubMed ID: 9665456
    [No Abstract]   [Full Text] [Related]  

  • 13. A radical approach is needed to eliminate interference from endogenous antibodies in immunoassays.
    Ismail AA
    Clin Chem; 2005 Jan; 51(1):25-6. PubMed ID: 15539464
    [No Abstract]   [Full Text] [Related]  

  • 14. Performance characteristics of four immunoassays for antiepileptic drugs on the IMMULITE 2000 automated analyzer.
    Frank EL; Schwarz EL; Juenke J; Annesley TM; Roberts WL
    Am J Clin Pathol; 2002 Jul; 118(1):124-31. PubMed ID: 12109846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Nephelometric inhibition immunoassay (NIIA), a new methodology for the determination of phenobarbital and phenytoin concentration in serum (author's transl)].
    Liappis N
    Klin Padiatr; 1982 Mar; 194(2):88-90. PubMed ID: 7047885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence of temperature-dependent interference in an immunonephelometric assay by monoclonal IgM.
    Granouillet R; Rascle F; Bonneau C; Chamson A; Frey J; Perier C
    Clin Chem; 1999 Nov; 45(11):2039-40. PubMed ID: 10545086
    [No Abstract]   [Full Text] [Related]  

  • 17. Measurement of immunoglobulins G, A, and M levels in B-lymphocytes culture.
    Grandjenette C; Kennel A; Massin F; Faure GC; Béné MC; Montagne P
    J Immunoassay Immunochem; 2005; 26(4):303-11. PubMed ID: 16153015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eliminating heterophilic antibody interference for ferritin detection using Olympus F(ab')2 based reagent.
    Grouzmann E; Dayer N; Bain C; Neville CM; McCusker MD; Wang RY
    Clin Lab; 2008; 54(9-10):355-7. PubMed ID: 19097493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Light-scattering immunoassay of specific proteins: a review.
    Price CP; Spencer K; Whicher J
    Ann Clin Biochem; 1983 Jan; 20 Pt 1():1-14. PubMed ID: 6340592
    [No Abstract]   [Full Text] [Related]  

  • 20. [Immunoglobulin M].
    Kubo N; Sakurabayashi I; Kawai T
    Nihon Rinsho; 2010 Jun; 68 Suppl 6():13-5. PubMed ID: 20941989
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.